Improve Sudden Cardiac Arrest Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 4222 participants.
Also called NCT02099721
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 4,222 participants
- Registry
-
NCT02099721
-
- Other papers using this trial's data
- Regional disparities and risk factors of mortality among patients at high risk of sudden cardiac death in emerging countries: a nonrandomized controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Argentina, Belarus, Brazil, China, Colombia, Egypt, India, Malaysia, Mexico, Russia, Singapore, South Africa, South Korea, Taiwan, Tunisia, United Arab Emirates
- Registry status
- Completed
Technical summary
Registry record NCT02099721. Non-randomized; no masking; primary purpose prevention. Start 2014-03 (actual); primary completion 2018-07-15 (actual). Results posted on 2020-10-28.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Improve Sudden Cardiac Arrest Study
- Condition
- Sudden Cardiac Arrest
- Condition
- Ventricular Arrythmia
- Intervention (Device)
- ICD or CRT-D Device
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
Record details
- Record id
cardio:ct-nct02099721- Content hash
1e20242808d7f482a962af3be88ee4d9f4d5bd9d3b436619c260f5d4e4f10403